NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NGGT Inc.

NGGT Inc.

Private
Walnut Creek, CaliforniaHealthcare & Life Scienceshttps://nggtbio.com/

Last Round

Series B

Jul 11, 2023

Total Funding Raised

$70M

Company Overview

NGGT Inc. is a biotechnology company that develops gene therapies for the treatment of rare genetic diseases, including retinal, metabolic, and neurodegenerative disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyAAVadeno-associated virusbiotechrare diseasevector technologygene therapeuticscGMP manufacturingclinical-stage biotechgenetic medicinedrug discoveryprecision medicinebiopharmaclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NGGT Inc. Comps

Public and private peers based on sector, stage, and business model.

NGGT Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NGGT Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 11, 2023
Series AApr 15, 2021
AngelJul 1, 2020

NGGT Inc. Investors

Notable investors and investment history

NGGT Inc. investors
InvestorRounds
Shanghai Healthcare CapitalSeries B
YuanBio Venture CapitalAngel, Series A
Northern Light Venture CapitalAngel, Series B, Series A
德同资本Series B
Infinity GroupSeries B

NGGT Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NGGT Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NGGT Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWalnut Creek, California
Employee Range2
Year Founded2020
Last FundingJul 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.